Autolus Therapeutics PLC (AUTL)
2.94
+0.10
(+3.52%)
USD |
NASDAQ |
Nov 22, 16:00
2.945
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Free Cash Flow: -205.61M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -205.61M |
| June 30, 2024 | -160.97M |
| March 31, 2024 | -151.58M |
| December 31, 2023 | -156.57M |
| September 30, 2023 | -145.46M |
| June 30, 2023 | -142.48M |
| March 31, 2023 | -133.39M |
| December 31, 2022 | -123.15M |
| September 30, 2022 | -118.69M |
| June 30, 2022 | -118.60M |
| Date | Value |
|---|---|
| March 31, 2022 | -123.28M |
| December 31, 2021 | -126.72M |
| September 30, 2021 | -149.18M |
| June 30, 2021 | -153.68M |
| March 31, 2021 | -145.01M |
| December 31, 2020 | -132.44M |
| September 30, 2020 | -134.42M |
| June 30, 2020 | -119.58M |
| March 31, 2020 | -112.98M |
| December 31, 2019 | -120.15M |
Free Cash Flow Range, Past 5 Years
-205.61M
Minimum
Sep 2024
-112.98M
Maximum
Mar 2020
-138.70M
Average
-133.90M
Median
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics PLC | -56.05M |
| TC BioPharm (Holdings) PLC | -15.84M |
| Biodexa Pharmaceuticals PLC | -11.12M |
| NuCana PLC | -22.00M |
| Bicycle Therapeutics PLC | -203.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -76.74M |
| Cash from Investing (Quarterly) | -9.589M |
| Cash from Financing (Quarterly) | 0.185M |
| Free Cash Flow Per Share (Quarterly) | -0.3244 |
| Free Cash Flow Yield | -30.13% |